Skip to main content
. 2014 Aug 12;2014:823093. doi: 10.1155/2014/823093

Figure 4.

Figure 4

The clinical course and the changes of patient's serum amyloid A (SAA) levels. The tocilizumab treatment controlled her SAA levels, although there were transient SAA level elevations due to a urinary tract infection.